- Filed
- May 4, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 25M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 24.35M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $1.62M |
| Capex | Q1 2026 · Mar 31, 2025 | $1.03M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $1.49M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $1.3M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $5.4M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $5.45M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $13.1M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $13.54M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $87.02M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $87.95M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $39.2M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $37.96M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $53.55M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $52.52M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $22.04M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $22.5M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $154.55M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $154.65M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.05 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.05 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.04 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.26M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$1.01M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.43M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.01M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $20.91M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $20.91M |
| Revenue | Q1 2026 · Mar 31, 2026 | $24.31M |
| Revenue | Q1 2026 · Mar 31, 2025 | $23.84M |